Cargando…

Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States

IMPORTANCE: Between 2 and 3.5 million people live with chronic hepatitis C virus (HCV) infection in the US, most of whom (approximately 75%) are not aware of their disease. Despite the availability of effective HCV treatment in the early stages of infection, HCV will result in thousands of deaths in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tatar, Moosa, Keeshin, Susana W., Mailliard, Mark, Wilson, Fernando A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489814/ https://www.ncbi.nlm.nih.gov/pubmed/32880650 http://dx.doi.org/10.1001/jamanetworkopen.2020.15756

Ejemplares similares

Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States
por: Guzauskas, Gregory F., et al.
Publicado: (2020)

Spatial Modeling of COVID-19 Vaccine Hesitancy in the United States
por: Mollalo, Abolfazl, et al.
Publicado: (2021)

Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States
por: Dixon, Dave L., et al.
Publicado: (2023)

Comparison of Use of Health Care Services and Spending for Unauthorized Immigrants vs Authorized Immigrants or US Citizens Using a Machine Learning Model
por: Wilson, Fernando A., et al.
Publicado: (2020)

Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020
por: Haslam, Alyson, et al.
Publicado: (2021)

Estimating Excess Deaths by Race/Ethnicity in the State of California During the COVID-19 Pandemic
por: Habibdoust, Amir, et al.
Publicado: (2022)

Expert Evaluation of Strategies to Modernize Newborn Screening in the United States
por: Bailey, Donald B., et al.
Publicado: (2021)

Evaluation of Amphetamine-Related Hospitalizations and Associated Clinical Outcomes and Costs in the United States
por: Winkelman, Tyler N. A., et al.
Publicado: (2018)

Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States
por: Ogawa, Eiichi, et al.
Publicado: (2020)

Hepatitis C and hepatitis B virus infections in the etiopathogenesis of pemphigus()
por: Demirci, Gulsen Tukenmez, et al.
Publicado: (2014)

Screening for Hepatitis C Virus: How Universal Is Universal?
por: Jhaveri, Ravi
Publicado: (2020)

Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States
por: Nguyen, Vy H., et al.
Publicado: (2022)

Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States
por: Razavi, Homie, et al.
Publicado: (2013)

Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation
por: Su, Shu, et al.
Publicado: (2022)

Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017
por: Cheng, Xingxing S., et al.
Publicado: (2022)

Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015
por: Sanford, Nina N., et al.
Publicado: (2019)

Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation
por: Vaidya, Riha, et al.
Publicado: (2023)

The largest vaccination campaign in history: A golden opportunity for bundling public health interventions
por: Tatar, Moosa, et al.
Publicado: (2021)

Cost-Effectiveness of Alternative Blood-Screening Strategies for West Nile Virus in the United States
por: Korves, Caroline T, et al.
Publicado: (2006)

Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016
por: Rosenberg, Eli S., et al.
Publicado: (2018)

Assessment of Selective and Universal Screening for Suicide Risk in a Pediatric Emergency Department
por: DeVylder, Jordan E., et al.
Publicado: (2019)

Trends in Incidence of Early-Onset Colorectal Cancer in the United States Among Those Approaching Screening Age
por: Abualkhair, Wesal H., et al.
Publicado: (2020)

Hepatitis A Hospitalization Costs, United States, 2017
por: Hofmeister, Megan G., et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States
por: Liu, Shan, et al.
Publicado: (2013)

Cost-effectiveness of Maintenance Therapy Based on Molecular Classification Following Treatment of Primary Epithelial Ovarian Cancer in the United States
por: Penn, Courtney A., et al.
Publicado: (2020)

Treatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021
por: Jaber Chehayeb, Rachel, et al.
Publicado: (2022)

Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States
por: Paltiel, A. David, et al.
Publicado: (2020)

Differences in Breast and Colorectal Cancer Screening Adherence Among Women Residing in Urban and Rural Communities in the United States
por: Shete, Sanjay, et al.
Publicado: (2021)

Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014
por: Wright, Jason D., et al.
Publicado: (2021)

Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023
por: Conners, Erin E., et al.
Publicado: (2023)

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
por: Chhatwal, Jagpreet, et al.
Publicado: (2019)

Cost Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Sarcomas or GI Stromal Tumors
por: Tan, Glorijoy, et al.
Publicado: (2016)

Cholesterol Screening by Marital Status and Sex in the United States
por: Stimpson, Jim P., et al.
Publicado: (2009)

Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States
por: Criss, Steven D., et al.
Publicado: (2019)

A synthetic lethal screen identifies HDAC4 as a potential target in MELK overexpressing cancers
por: Zhou, Lin, et al.
Publicado: (2021)

Large-Scale Screening for Targeted Knockouts in the Caenorhabditis elegans Genome
Publicado: (2012)

Regional Differences in Mortality Rates and Characteristics of Decedents With Hepatitis B Listed as a Cause of Death, United States, 2000-2019
por: Ly, Kathleen N., et al.
Publicado: (2022)

Air Pollution, Socioeconomic Status, and Age-Specific Mortality Risk in the United States
por: Boing, Antonio Fernando, et al.
Publicado: (2022)

Ending hepatitis C in the United States: the role of screening
por: Coffin, Phillip O, et al.
Publicado: (2014)

Assessment of Costs of Avoidable Delays in Intensive Care Unit Discharge
por: Bagshaw, Sean M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uajutt8095o5eg0be596jv5ktn